After the jackpot, the bet

With a gain of 100 million from Cominar, businessman George Armoyan acquires 10% of Knight Therapeutics

After making a profit of nearly $100 million in less than two years with Cominar during the pandemic, Montreal businessman George Armoyan is turning his attention to another Quebec company.

Continue Reading

G2S2 CAPITAL INC. FILES EARLY WARNING REPORT FOR INVESTMENT IN CALFRAC WELL SERVICES LTD.

HALIFAX, NS, Nov. 15, 2023 /CNW/ – G2S2 Capital Inc. (“G2S2”) announces that it has acquired ownership of, and control over, 28,400 common shares (“Shares”) of Morguard Corporation (“Morguard”).

Continue Reading

G2S2 Capital Inc. Requisitions Special Meeting of Slate Office REIT Unitholders, Nominates Four Highly Qualified Nominees to Align Board with Unitholders Interests, and Highlights Strategy to Unlock Value for Unitholders

  • G2S2 requisitions special meeting of SOT unitholders
  • Nominates four highly experienced and independent nominees
  • Calls for further changes of board composition by removing conflicted trustees, amending Declaration of Trust to right-size the number of SLAM’s board nomination rights from two trustees to one
  • Outlines strategic plan to enhance capital allocation, align unitholder interests through improved board oversight and conduct an in-depth review of each property to determine its highest and best use
  • Cautions fellow unitholders that hastily announced “strategic review” by conflicted and entrenched existing trustees of the REIT is a transparent and self-interested delay tactic
Continue Reading

G2S2 CAPITAL INC. ANNOUNCES INCREASED INVESTMENT IN SLATE OFFICE REIT

HALIFAX, NS, Oct. 25, 2022 /CNW/ – G2S2 Capital Inc. (“G2S2”) announces that its wholly owned subsidiary has acquired $7,100,000 principal amount of 7.50% Convertible Unsecured Subordinated Debentures (“Convertible Debentures”) of Slate Office REIT (“Slate Office”).

Continue Reading

G2S2 Capital Inc. Issues Open Letter to Slate Office REIT Unitholders

  • Publishes open letter to Slate Office REIT unitholders expressing its disappointment in management’s performance and lack of accountability
  • Highlights various instances of misaligned interests, unitholder value destruction, and incoherent strategic direction
  • Announces intention to requisition a timely meeting of unitholders
Continue Reading

G2S2 CAPITAL INC. FILES EARLY WARNING REPORT FOR INVESTMENT IN CALFRAC WELL SERVICES LTD.

HALIFAX, NS, Sept. 22, 2022 /CNW/ – G2S2 Capital Inc. (“G2S2”) announces that Clarke Inc. Master Trust (“Clarke MT”), an entity with whom G2S2 is deemed to be a joint actor, has disposed of 326,000 common shares (“Common Shares”) of Calfrac Well Services Ltd. (“Calfrac”).

Continue Reading

G2S2 CAPITAL INC. FILES EARLY WARNING REPORT FOR INVESTMENT IN CALFRAC WELL SERVICES LTD.

HALIFAX, NS, Sept. 20, 2022 /CNW/ – G2S2 Capital Inc. (“G2S2”) announces that Clarke Inc. Master Trust (“Clarke MT”), an entity with whom G2S2 is deemed to be a joint actor, has disposed of 489,000 common shares (“Common Shares”) of Calfrac Well Services Ltd. (“Calfrac”).

Continue Reading

G2S2 CAPITAL INC. ANNOUNCES INCREASED INVESTMENT IN SLATE OFFICE REIT

HALIFAX, NS, Sept. 19, 2022 /CNW/ – G2S2 Capital Inc. (“G2S2”) announces today that its wholly owned subsidiary has increased its ownership of trust units (“Units”) of Slate Office REIT (“Slate Office”) to 14.34% of Slate Office’s outstanding Units.  

Continue Reading

G2S2 CAPITAL INC. ANNOUNCES INCREASED INVESTMENT IN CLARKE INC.

HALIFAX, NS, Aug. 19, 2022 /CNW/ – G2S2 Capital Inc. (“G2S2”) announces that it has acquired ownership of, and control over, an additional $246,000 principal amount of Clarke Inc. Convertible Debentures (“Convertible Debentures”) which, if converted, would entitle G2S2 to 17,904 common shares of Clarke Inc. (“Clarke”) and represent 0.12% of the outstanding common shares of Clarke (“Common Shares”). G2S2 acquired the Convertible Debentures on August 18, 2022, through the facilities of the Toronto Stock Exchange at a price of $989.65 per $1,000 of principal (the “Acquisition”).

Continue Reading

G2S2 CAPITAL INC. FILES EARLY WARNING REPORT FOR INVESTMENT IN KNIGHT THERAPEUTICS INC.

HALIFAX, NS, Aug. 11, 2022 /CNW/ – G2S2 Capital Inc. (“G2S2”) announces that its wholly owned subsidiary has disposed of common shares (“Shares”) of Knight Therapeutics Inc. (“Knight”) and no longer holds over 10% of Knight’s outstanding Shares.  

Continue Reading
Scroll to top